50 Biggest Movers From Yesterday

Gainers

  • electroCore, Inc. ECOR shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for PTSD treatment.
  • Immuron Limited IMRN shares surged 49.6% to close at $3.83 on Wednesday. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing regimen for Travelan more suited for use by the military.
  • SurgePays, Inc. SURG gained 32.1% to close at $2.80. The company recently announced 30,000 SurgePhone Wireless subscribers in December.
  • Nxt-ID, Inc. NXTD surged 30.6% to settle at $4.14.
  • Vaxxinity, Inc. VAXX gained 29.7% to close at $7.56 after the company announced the first Parkinson's disease patient has been dosed in Part B of a Phase 1 clinical trial of UB-312.
  • Fathom Digital Manufacturing Corporation FATH shares jumped 29% to close at $6.85.
  • Vinco Ventures, Inc. BBIG climbed 23.1% to close at $2.88.
  • Pintec Technology Holdings Limited PT gained 21.1% to settle at $0.6299.
  • Kidpik Corp. PIK jumped 20.7% to close at $7.30 after jumping more than 27% on Tuesday. Kidpik, last month, posted a Q3 loss of $0.22 per share.
  • Fresh Vine Wine, Inc. VINE gained 19.9% to close at $6.98 after the company reported a partnership with CRAVE American Kitchen & Sushi Bar.
  • Merida Merger Corp. I MCMJ gained 19.3% to close at $10.01. Leafly and Merida Merger Corp. I reported a $30 million convertible note financing.
  • BTCS Inc. BTCS rose 19% to settle at $6.70.
  • Immix Biopharma, Inc. IMMX jumped 18.4% to settle at $6.43 after the company announced preclinical data of its lead program, IMX-110. The data showed that IMX-110 produced a 50% response rate in first-line-therapy-resistant cancer - soft tissue sarcoma (STS) mouse study, surpassing the STS standard of care doxorubicin’s 0% response rate in the same mouse study.
  • Vigil Neuroscience, Inc. VIGL gained 18% to close at $14.00 amid post-IPO volatility.
  • Smart Share Global Limited EM jumped 16.7% to settle at $2.24.
  • CI&T Inc. CINT gained 16.7% to close at $13.61.
  • Ebix, Inc. EBIX climbed 15.3% to close at $35.80.
  • Vir Biotechnology, Inc. VIR gained 15.1% to settle at $40.01 following Tuesday's announcement the US government will purchase an additional 600,000 doses of sotrovimab.
  • Ucommune International Ltd UK jumped 14.8% to settle at $0.7350.
  • Mainz Biomed B.V. MYNZ gained 14.4% to close at $16.12. Mainz Biomed recently announced it acquired exclusive rights to novel mRNA biomarkers.
  • U.S. Global Investors, Inc. GROW rose 13.9% to settle at $5.81. US Global Investors recently posted Q1 EPS of $0.16.
  • OceanPal Inc. OP gained 13.3% to close at $2.21.
  • Planet Labs PBC PL shares climbed 10.5% to close at $6.23 after Goldman Sachs initiated coverage on the stock with a Buy rating and a $11 price target.
  • Qutoutiao Inc. QTT climbed 10.1% to settle at $3.06. Shares of several Chinese companies traded higher following data that showed China's inflation rose slower than expected in December, which increased policy easing optimism.
  • Jaguar Health, Inc. JAGX gained 9.7% to close at $1.02 following a 13G filing from Oasis Capital showing a 9.99% stake in the company.
  • 51job, Inc. JOBS shares gained 9.1% to settle at $50.00. 51job reported receipt of a proposal to amend merger consideration for going-private transaction.
  • inTEST Corporation INTT rose 7.9% to close at $12.89.
  • Sonendo, Inc. SONX gained 6.4% to close at $7.18. Sonendo recently issued Q4 and FY21 sales guidance above estimates.

 


Check out these big penny stock gainers and losers

Losers

  • Avinger, Inc. AVGR shares dipped 25.7% to settle at $0.3571 on Wednesday after the company announced a $7.6 million registered direct offering.
  • Dogness (International) Corporation DOGZ dropped 19.8% to close at
  • $2.91.
  • Nutriband Inc. NTRB shares declined 17.3% to close at $6.74.
  • Nam Tai Property Inc. NTP fell 16.9% to close at $9.58 on Wednesday. Nam Tai Property issued an update on local affairs and efforts to preserve social stability.
  • Kanzhun Limited BZ fell 15.6% to settle at $30.66.
  • Reviva Pharmaceuticals Holdings, Inc. RVPH tumbled 15.4% to settle at $2.36. The FDA recently notified Reviva Pharmaceuticals that it may proceed with Phase 3 trial of its lead candidate, brilaroxazine, a serotonin and dopamine receptor modulator for schizophrenia.
  • Hour Loop, Inc. HOUR fell 14.9% to close at $5.73. The company recently priced its IPO at $4 per share.
  • TDH Holdings, Inc. PETZ dipped 14.8% to settle at $0.5859 on above-average volume despite not seeing any seeing any company-specific news.
  • Theravance Biopharma, Inc. TBPH shares fell 14.8% to close at $9.51. Theravance Biopharma recently reported enrollment of first patient in YUPELRI® Phase 4 study.
  • Koninklijke Philips N.V. PHG shares dipped 14.7% to settle at $33.09 on Wednesday after the company hiked the cost of its recall of ventilators and warned earnings would take a big hit from global supply chain shortages.
  • Bone Biologics Corporation BBLG tumbled 14% to close at $3.7050.
  • Kronos Bio, Inc. KRON fell 13.8% to close at $11.04.
  • Aclaris Therapeutics, Inc. ACRS fell 13.6% to close at $11.11. Providing a R&D update, Aclaris Therapeutics said David Gordon, its chief medical officer left the company, effective Jan. 7. The company also announced update on its two Phase 2 programs that evaluate zunsemetinib in subjects with moderate to severe rheumatoid arthritis and in subjects with moderate to severe hidradenitis suppurative.
  • Pop Culture Group Co., Ltd CPOP dipped 13.5% to settle at $2.05.
  • ATA Creativity Global AACG fell 12.2% to close at $2.01.
  • Prothena Corporation plc PRTA shares dropped 11% to close at $37.47 on Wednesday.
  • Nisun International Enterprise Development Group Co., Ltd NISN fell 10.7% to settle at $2.26. Nisun recently reported a cooperative supply chain agreement with Henan Shiwugu.
  • Phio Pharmaceuticals Corp. PHIO shares declined 10% to close at $0.9271. Phio Pharmaceuticals shares gained 8% on Tuesday after the company announced regulatory clearance of the clinical trial of PH-762 to treat melanoma.
  • Jefferies Financial Group Inc. JEF fell 9.3% to close at $37.59 after the company reported worse-than-expected Q4 sales results.
  • Wipro Limited WIT fell 8.5% to close at $8.70 following Q3 results. The company reported third-quarter FY22 gross revenue of $2.7 billion, an increase of 3.3% Q/Q and 29.6% Y/Y.
  • Lucira Health, Inc. LHDX shares fell 7.3% to close at $7.46. The company recently said that its Lucira™ Check-It PCR-Quality, At-Home Molecular COVID-19 Test is now available in the Optum Store.
  • Biogen Inc. BIIB fell 6.7% to settle at $225.34 following a U.S. Centers For Medicare listing for "Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease."
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!